Malignant pleural effusion survival prognostication in an Asian population

J. Quek (Singapore, Singapore), Q. Tan (Singapore, Singapore), J. Wong (Singapore, Singapore), J. Carter (Singapore, Singapore), D. Anantham (Singapore, Singapore)

Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Session: Brain Metastasis and Malignant pleural effusion: improving our understanding
Session type: Oral Presentation
Number: 3799
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Quek (Singapore, Singapore), Q. Tan (Singapore, Singapore), J. Wong (Singapore, Singapore), J. Carter (Singapore, Singapore), D. Anantham (Singapore, Singapore). Malignant pleural effusion survival prognostication in an Asian population. 3799

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Malignant pleural effusion - diagnosis and treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Malignant pleural effusion: different treatments through countries
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001

Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015




Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017


Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006

Incidence of lung entrapment in malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012

Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019